OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BIZ$4.7457

Business Alignment PCL

Medical Equipment, Supplies & DistributionVerified

Business Alignment PCL has a market price of 4.74 THB and a market cap of 2.85 billion THB, with a price-to-earnings ratio of 9.32 and a price-to-book ratio of 2.93. The company's liquidity position is characterized by a current ratio of 2.13, but it has negative net cash after subtracting total debt, indicating a medium liquidity risk. The company's debt-to-equity ratio is 0.38, suggesting a relatively conservative capital structure. In terms of profitability, Business Alignment PCL has a return on equity of 31.39% and a return on assets of 15.44%, which are strong indicators of efficient use of equity and assets. The company's operating margin is 18.84% (calculated from operating income of 380.74 million THB on revenue of 2.02 billion THB), which is a key metric for the industry. These figures suggest that the company is performing well compared to industry standards. The company's revenue is split between two segments: Sales of Medical Equipment and Hospital Operations. The Sales of Medical Equipment segment includes installation and related activities, while the Hospital Operations segment specializes in cancer treatment. The company's geographic exposure is primarily in Thailand, with customers including university-affiliated hospitals, cancer hospitals, the Ministry of Public Health, and private hospitals. Business Alignment PCL's growth trajectory is reflected in its financial performance. The company's revenue for the latest period is 2.02 billion THB, with a gross profit of 488.14 million THB. The company's outlook for the current fiscal year is positive, with expected growth in revenue and profitability. The company's capital expenditure for the period is -1.50 million THB, indicating a reduction in capital spending. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flags include negative net cash after subtracting total debt, which could affect the company's ability to meet short-term obligations. The company's dilution potential is low, with no significant dilution sources identified in the latest filings. Recent events and filings for Business Alignment PCL include the latest financial snapshot, which provides insights into the company's financial health. The company's free cash flow is 114.71 million THB, indicating a positive cash flow from operations after capital expenditures. The company's operating cash flow is -250.11 million THB, which is a concern for liquidity management.

30-day price · BIZ+0.18 (+3.9%)
Low$4.56High$4.86Close$4.82As of15 May, 00:00 UTC
Profile
CompanyBusiness Alignment PCL
TickerBIZ.BK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Business Alignment PCL distributes and installs medical equipment for cancer treatment through radiotherapy and operates a specialized cancer treatment hospital in Thailand, serving university-affiliated hospitals, cancer hospitals, the Ministry of Public Health, and private hospitals.

Classification. Business Alignment PCL is classified in the industry "Medical Equipment, Supplies & Distribution" under the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Business Alignment PCL has a market price of 4.74 THB and a market cap of 2.85 billion THB, with a price-to-earnings ratio of 9.32 and a price-to-book ratio of 2.93. The company's liquidity position is characterized by a current ratio of 2.13, but it has negative net cash after subtracting total debt, indicating a medium liquidity risk. The company's debt-to-equity ratio is 0.38, suggesting a relatively conservative capital structure. In terms of profitability, Business Alignment PCL has a return on equity of 31.39% and a return on assets of 15.44%, which are strong indicators of efficient use of equity and assets. The company's operating margin is 18.84% (calculated from operating income of 380.74 million THB on revenue of 2.02 billion THB), which is a key metric for the industry. These figures suggest that the company is performing well compared to industry standards. The company's revenue is split between two segments: Sales of Medical Equipment and Hospital Operations. The Sales of Medical Equipment segment includes installation and related activities, while the Hospital Operations segment specializes in cancer treatment. The company's geographic exposure is primarily in Thailand, with customers including university-affiliated hospitals, cancer hospitals, the Ministry of Public Health, and private hospitals. Business Alignment PCL's growth trajectory is reflected in its financial performance. The company's revenue for the latest period is 2.02 billion THB, with a gross profit of 488.14 million THB. The company's outlook for the current fiscal year is positive, with expected growth in revenue and profitability. The company's capital expenditure for the period is -1.50 million THB, indicating a reduction in capital spending. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flags include negative net cash after subtracting total debt, which could affect the company's ability to meet short-term obligations. The company's dilution potential is low, with no significant dilution sources identified in the latest filings. Recent events and filings for Business Alignment PCL include the latest financial snapshot, which provides insights into the company's financial health. The company's free cash flow is 114.71 million THB, indicating a positive cash flow from operations after capital expenditures. The company's operating cash flow is -250.11 million THB, which is a concern for liquidity management.
Key takeaways
  • Business Alignment PCL has a strong return on equity of 31.39% and a return on assets of 15.44%, indicating efficient use of equity and assets.
  • The company's liquidity position is characterized by a current ratio of 2.13, but it has negative net cash after subtracting total debt, indicating a medium liquidity risk.
  • Business Alignment PCL's revenue is split between two segments: Sales of Medical Equipment and Hospital Operations, with a primary geographic exposure in Thailand.
  • The company's growth trajectory is reflected in its financial performance, with a revenue of 2.02 billion THB and a gross profit of 488.14 million THB.
  • The company's risk assessment indicates a medium liquidity risk and a low dilution risk, with key flags including negative net cash after subtracting total debt.
  • # RATIONALES
  • margin_outlook_rationale: The company's operating margin is expected to remain stable due to consistent demand for medical equipment and hospital services.
  • rd_outlook_rationale: Research and development expenditures are expected to remain low as the company focuses on distribution and installation services.
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$2.02B
Gross profit$488.1M
Operating income$380.7M
Net income$305.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$250.1M
CapEx-$1.5M
Free cash flow$114.7M
Total assets$1.98B
Total liabilities$1.01B
Total equity$973.4M
Cash & equivalents$154.1M
Long-term debt$365.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$4.74
Market cap$2.85B
Enterprise value$3.06B
P/E9.3
Reported non-GAAP P/E
EV/Revenue1.5
EV/Op income8.0
EV/OCF
P/B2.9
P/Tangible book2.9
Tangible book$973.4M
Net cash-$211.4M
Current ratio2.1
Debt/Equity0.4
ROA15.4%
ROE31.4%
Cash conversion-82.0%
CapEx/Revenue-0.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
MetricBIZActivity
Op margin18.8%13.3% medp25 5.9% · p75 13.5%top quartile
Net margin15.1%8.6% medp25 2.7% · p75 12.7%top quartile
Gross margin24.1%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-0.1%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity38.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:59 UTC#492f90f6
Market quoteclose THB 4.74 · shares 0.60B diluted
no public URL
2026-05-10 08:59 UTC#b6acb492
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:01 UTCJob: 346d1c53